Clinical implementation of MR-guided vaginal cylinder brachytherapy

被引:6
作者
Owrangi, Amir M. [1 ]
Jolly, Shruti [1 ]
Balter, James M. [1 ]
Cao, Yue [1 ]
Maturen, Katherine E. [2 ]
Young, Lisa [1 ]
Zhu, Tong [1 ]
Prisciandaroa, Joann I. [1 ]
机构
[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
关键词
brachytherapy; MRI; applicator reconstruction; CERVIX CANCER BRACHYTHERAPY; DOSE-RATE BRACHYTHERAPY; QUALITY-OF-LIFE; ENDOMETRIAL CANCER; APPLICATOR RECONSTRUCTION; COMPUTED-TOMOGRAPHY; VAULT BRACHYTHERAPY; HDR BRACHYTHERAPY; RECOMMENDATIONS; PORTEC-2;
D O I
10.1120/jacmp.v16i6.5460
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We present an institutional experience on the clinical implementation of magnetic resonance (MR)-guided vaginal brachytherapy using commercially available solid applicator models. To test the fidelity of solid applicator models to digitize vaginal cylinder applicators, three datasets were evaluated. The first included 15 patients who were simulated with CT alone. Next, a water phantom was used to evaluate vaginal cylinders ranging from 20 to 35 mm in diameter with CT and MR. Finally, three patients undergoing HDR brachytherapy with vaginal cylinders that were simulated with both CT and MR were evaluated. In these assessments, the solid applicator models were aligned based on the outline of the applicators on the corresponding volumetric image, and deviations between the central source positions defined based on X-ray markers (on CT) and solid applicator models (on CT and MR), and the percent dose difference between select reference points were calculated. The mean central source deviation defined based on X-ray markers (on CT) and solid applicator models (on CT and MR) for the 15-patient cohort, the phantom, and the 3-patient cohort is 0.6 mm, 0.6 mm, and 1.2 mm, respectively. The average absolute percent dose difference for the bladder, rectum, prescription, and inferior reference points were 2.2%, 2.3%, 2.2%, and 2.4%, respectively, for the 15 patient cohort. For the phantom study, the average, absolute percent dose difference for the prescription and inferior reference points are 2.0% and 2.1% for the CT, 2.3% and 2.2% for the T1W, and 2.8% and 3.0% for the T2W images. For the three patient cohort, the average absolute percent dose difference for the bladder, rectum, prescription, and inferior reference points are 2.9%, 2.6%, 3.0%, and 4.2% for the CT, 6.5%, 1.6%, 2.5%, and 4.7% for the T1W, and 6.0%, 7.4%, 2.6, and 2.0% for the T2W images. Based on the current study, aligning the applicator model to MR images provides a practical, efficient approach to perform MR-based brachytherapy planning.
引用
收藏
页码:490 / 500
页数:11
相关论文
共 36 条
[1]  
[Anonymous], 1985, ICRU Report 38
[2]  
[Anonymous], MAGNETOM FLASH
[3]  
[Anonymous], BRACHYTHERAPY
[4]   Brachytherapy in endometrial cancer: Quantification of air gaps around a vaginal cylinder [J].
Cameron, Alison L. ;
Cornes, Paul ;
Al-Booz, Hoda .
BRACHYTHERAPY, 2008, 7 (04) :355-358
[5]   Evaluation of PC-ISO for customized, 3D printed, gynecologic 192Ir HDR brachytherapy applicators [J].
Cunha, J. Adam M. ;
Mellis, Katherine ;
Sethi, Rajni ;
Siauw, Timmy ;
Sudhyadhom, Atchar ;
Garg, Animesh ;
Goldberg, Ken ;
Hsu, I-Chow ;
Pouliot, Jean .
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2015, 16 (01) :246-253
[6]   Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy [J].
Dimopoulos, Johannes C. A. ;
Petrow, Peter ;
Tanderup, Kari ;
Petric, Primoz ;
Berger, Daniel ;
Kirisits, Christian ;
Pedersen, Erik M. ;
van Limbergen, Erik ;
Haie-Meder, Christine ;
Poetter, Richard .
RADIOTHERAPY AND ONCOLOGY, 2012, 103 (01) :113-122
[7]   Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy [J].
Dimopoulos, Johannes C. A. ;
Poetter, Richard ;
Lang, Stefan ;
Fidarova, Elena ;
Georg, Petra ;
Doerr, Wolfgang ;
Kirisits, Christian .
RADIOTHERAPY AND ONCOLOGY, 2009, 93 (02) :311-315
[8]   Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer [J].
Haack, Soren ;
Nielsen, Soren Kynde ;
Lindegaard, Jacob Christian ;
Gelineck, John ;
Tanderup, Kari .
RADIOTHERAPY AND ONCOLOGY, 2009, 91 (02) :187-193
[9]   Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group* (I):: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV [J].
Haie-Meder, C ;
Pötter, R ;
Van Limbergen, E ;
Briot, E ;
De Brabandere, M ;
Dimopoulos, J ;
Dumas, I ;
Hellebust, TP ;
Kirisits, C ;
Lang, SF ;
Muschitz, S ;
Nevinson, J ;
Nulens, A ;
Petrow, P ;
Wachter-Gerstner, N .
RADIOTHERAPY AND ONCOLOGY, 2005, 74 (03) :235-245
[10]   Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: Considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy [J].
Hellebust, Taran Paulsen ;
Kirisits, Christian ;
Berger, Daniel ;
Perez-Calatayud, Jose ;
De Brabandere, Marisol ;
De Leeuw, Astrid ;
Dumas, Isabelle ;
Hudej, Robert ;
Lowe, Gerry ;
Wills, Rachel ;
Tanderup, Kari .
RADIOTHERAPY AND ONCOLOGY, 2010, 96 (02) :153-160